Publications by authors named "Brian D Lee"

Claim this Profile
T
Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis.
Katelyn F Woolridge, Patrick L Boler, Brian D Lee

Cutis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Land cover diversity increases predator aggregation and consumption of prey.
Hannah J Penn, Kacie J Athey, Brian D Lee

Ecol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance.
Paul F FitzGerald, Matthew D Butts, Jeannette C Roberts, Robert E Colborn, Andrew S Torres, Brian D Lee

Invest Radiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous pilomatricoma: a rarely reported variant of pilomatricoma.
Catherine M DiGiorgio, Nadine M Kaskas, Ryan J Matherne, Amie B Shannon, Brian D Lee

Dermatol Online J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
Jack M Webster, Christine A Morton, Bruce F Johnson, Hua Yang, Michael J Rishel, Brian D Lee

J Nucl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.
Qiaoyun Shi, Laura J Pisani, Yauk K Lee, Solomon Messing, Celina Ansari, Brian D Lee

Contrast Media Mol Imaging· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agent.
Andrew S Torres, Peter J Bonitatibus, Robert E Colborn, Gregory D Goddard, Paul F FitzGerald, Brian D Lee

Invest Radiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agent.
Peter J Bonitatibus, Andrew S Torres, Binil Kandapallil, Brian D Lee, Greg D Goddard

ACS Nano· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice.
Brian D Lee, Sabina Sevcikova, Scott C Kogan

Leuk Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008.
Brian D Lee, Kevin J French, Yan Zhuang, Charles D Smith

Oncol Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
Brian D Lee, Zhanjiang Li, Kevin J French, Yan Zhuang, Zuping Xia

J Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of inhibitors of human sphingosine kinase.
Kevin J French, Randy S Schrecengost, Brian D Lee, Yan Zhuang, Staci N Smith

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis